Stryker declares a $0.575 per share quarterly dividend

Kalamazoo, Michigan, Feb. 05, 2020 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan February 5, 2020 Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on April 30, 2020 to shareholders of record at the close of business on March 31, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.

Metadata

Provider:

GlobeNewswire, Inc.

Retrieved on:

Wednesday, February 5, 2020

Information

Tags:

Academic journals, Kalamazoo, Michigan, Spine, Periodicals, Publications

Geotags:

Portage, MI, Us

Organisation:

STRYKER CORPORATION

Summary

Key Points:

Kalamazoo, Michigan, Feb. 05, 2020 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan February 5, 2020 Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on April 30, 2020 to shareholders of record at the close of business on March 31, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.
Stryker is one of the worlds leading medical technology companies and, together with its customers, is driven to make healthcare better.
The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
For investor inquiries please contact:
For media inquiries please contact:

Kalamazoo, Michigan, Feb. 05, 2020 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – February 5, 2020 – Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on April 30, 2020 to shareholders of record at the close of business on March 31, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.

Contacts

For investor inquiries please contact:
Katherine Owen, Vice President, Strategy & Investor Relations at 269-385-2600 or [email protected]

For media inquiries please contact:
Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or [email protected]